SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 24932537.
  • 2
    McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119: 22502294.
  • 3
    Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54( 1 Suppl): S4354.
  • 4
    Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43( 12 Suppl S): 40S47S.
  • 5
    Shors SM, Cotts WG, Pavlovic-Surjancev B, Francois CJ, Gheorghiade M, Finn JP. Heart failure: evaluation of cardiopulmonary transit times with time-resolved MR angiography. Radiology 2003; 229: 743748.
  • 6
    Kellenberger E, Springael JY, Parmentier M, Hachet-Haas M, Galzi JL, Rognan D. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. J Med Chem 2007; 50: 12941303.
  • 7
    Ley S, Kauczor HU. MR imaging/magnetic resonance angiography of the pulmonary arteries and pulmonary thromboembolic disease. Magn Reson Imaging Clin N Am 2008; 16: 263273, ix.
  • 8
    Carr JC, Laub G, Zheng J, Pereles FS, Finn JP. Time-resolved three-dimensional pulmonary MR angiography and perfusion imaging with ultrashort repetition time. Acad Radiol 2002; 9: 14071418.
  • 9
    Korperich H, Gieseke J, Esdorn H, et al. Ultrafast time-resolved contrast-enhanced 3D pulmonary venous cardiovascular magnetic resonance angiography using SENSE combined with CENTRA-keyhole. J Cardiovasc Magn Reson 2007; 9: 7787.
  • 10
    Ley S, Fink C, Zaporozhan J, et al. Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol 2005; 15: 22562263.
  • 11
    La Vecchia L, Zanolla L, Varotto L, et al. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J 2001; 142: 181189.
  • 12
    Cashen TA, Jeong H, Shah MK, et al. 4D radial contrast-enhanced MR angiography with sliding subtraction. Magn Reson Med 2007; 58: 962972.
  • 13
    Eddleman CS, Jeong H, Cashen TA, et al. Advanced noninvasive imaging of spinal vascular malformations. Neurosurg Focus 2009; 26: E9.
  • 14
    Eddleman CS, Jeong HJ, Hurley MC, et al. 4D radial acquisition contrast-enhanced MR angiography and intracranial arteriovenous malformations: quickly approaching digital subtraction angiography. Stroke 2009; 40: 27492753.
  • 15
    Jeong HJ, Cashen TA, Hurley MC, et al. Radial sliding-window magnetic resonance angiography (MRA) with highly-constrained projection reconstruction (HYPR). Magn Reson Med 2009; 61: 11031113.
  • 16
    Riederer SJ, Tasciyan T, Farzaneh F, Lee JN, Wright RC, Herfkens RJ. MR fluoroscopy: technical feasibility. Magn Reson Med 1988; 8: 115.
  • 17
    Lakoma A, Tuite D, Sheehan J, Weale P, Carr JC. Measurement of pulmonary circulation parameters using time-resolved MR angiography in patients after Ross procedure. AJR Am J Roentgenol 2010; 194: 912919.
  • 18
    Obuchowski NA, Lieber ML. Confidence intervals for the receiver operating characteristic area in studies with small samples. Acad Radiol 1998; 5: 561571.
  • 19
    Ou LC, Sardella GL, Hill NS, Thron CD. Possible role of pulmonary blood volume in chronic hypoxic pulmonary hypertension. J Appl Physiol 1993; 74: 30203026.
  • 20
    Francois CJ, Shors SM, Bonow RO, Finn JP. Analysis of cardiopulmonary transit times at contrast material-enhanced MR imaging in patients with heart disease. Radiology 2003; 227: 447452.
  • 21
    Mostardi PM, Haider CR, Rossman PJ, Borisch EA, Riederer SJ. Controlled experimental study depicting moving objects in view-shared time-resolved 3D MRA. Magn Reson Med 2009; 62: 8595.
  • 22
    Huang Y, Wright GA. Time-resolved MR angiography with limited projections. In: Proc 15th Annual Meeting ISMRM, Berlin; 2007: 181.
  • 23
    Jeong H, Shah S, Eddleman CS, Sheehan JJ, Carr JC, Carroll TJ. Time-resolved MRA using radial multi-echo sequence and sliding window reconstruction. In: Proc 17th Annual Meeting ISMRM, Honolulu; 2009: 4723.
  • 24
    Rich S, Chomka E, Hasara L, et al. The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. Chest 1989; 96: 236241.
  • 25
    Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888894.
  • 26
    Hany TF, McKinnon GC, Leung DA, Pfammatter T, Debatin JF. Optimization of contrast timing for breath-hold three-dimensional MR angiography. J Magn Reson Imaging 1997; 7: 551556.